- Home
- TVTX vs HRMY Comparison
TVTX vs HRMY Comparison
Compare TVTX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- HRMY
- Stock Information
- Founded
- TVTX 2008
- HRMY 2017
- Country
- TVTX United States
- HRMY United States
- Employees
- TVTX N/A
- HRMY N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- TVTX Health Care
- HRMY Health Care
- Exchange
- TVTX Nasdaq
- HRMY Nasdaq
- Market Cap
- TVTX 1.9B
- HRMY N/A
- IPO Year
- TVTX N/A
- HRMY 2020
- Fundamental
- Price
- TVTX $17.44
- HRMY $32.42
- Analyst Decision
- TVTX Strong Buy
- HRMY Strong Buy
- Analyst Count
- TVTX 13
- HRMY 8
- Target Price
- TVTX $33.08
- HRMY $54.00
- AVG Volume (30 Days)
- TVTX 1.5M
- HRMY 647.7K
- Earning Date
- TVTX 05-05-2025
- HRMY 04-29-2025
- Dividend Yield
- TVTX N/A
- HRMY N/A
- EPS Growth
- TVTX N/A
- HRMY 17.84
- EPS
- TVTX N/A
- HRMY 2.51
- Revenue
- TVTX $233,175,000.00
- HRMY $714,734,000.00
- Revenue This Year
- TVTX $71.39
- HRMY $20.06
- Revenue Next Year
- TVTX $55.24
- HRMY $18.40
- P/E Ratio
- TVTX N/A
- HRMY $13.22
- Revenue Growth
- TVTX 60.55
- HRMY 22.80
- 52 Week Low
- TVTX $5.12
- HRMY $28.14
- 52 Week High
- TVTX $25.29
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- TVTX 34.91
- HRMY 39.56
- Support Level
- TVTX $20.29
- HRMY $32.85
- Resistance Level
- TVTX $20.98
- HRMY $33.77
- Average True Range (ATR)
- TVTX 1.00
- HRMY 1.23
- MACD
- TVTX -0.23
- HRMY -0.03
- Stochastic Oscillator
- TVTX 2.01
- HRMY 10.30
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.